SUMMARY A slight rearrangement of the data included in a recent report from the Radiation Effects Research Foundation (RERF) has shown differences between cardiovascular and other non-malignant diseases of A-bomb survivors which probably result from two factors: selection effects of early infection deaths and residual effects of marrow damage. Both effects were dose related but neither was obvious becasue one reduced the risk of later infection deaths and the other increased the risk. Allowance for these factors is bound to alter present RERF estimates for cancer effects of radiation and the change will probably be in an upward direction, thus bringing these estimates closer to ones based on radiation workers.
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It is widely believed that in less than five years after exposure to tissue destructive doses of ionising radiations there will be (apart from cancer) no further life shortening effects of the radiation. This belief is based on the mortality experiences of Abomb survivors as interpreted by epidemiologists on the staff of the Radiation Effects Research Foundation (RERF).11 The RERF study population of survivors was assembled five years after the bombing of Hiroshima and Nagasaki and is a source of risk estimates of cancer effects of radiation that are incorporated in ICRP recommendations (International Commission on Radiation Protection),4 but are very different from much higher estimates based on a survey of American workers in the nuclear industry.5 Therefore, if there has been faulty interpretation of the Japanese data there will be many ramifications.
All published analyses of RERF data implicitly assume a monotone dose effect curve for all causes of mortality. This means that no one has been prepared to consider the possibility of any dose response curve having oppositely directed slopes at high and low dose levels as a result of survivors with high and low doses having different reactions to, say, infections. This possibility was first mentioned in a recent review of RERF publications,6 and, in subsequent correspondence,7 attention was drawn to the fact that for several groups of non-cancer deaths included in the 8th mortality report2 there was evidence of a significant dip in the middle of the dose response curve. In other words the dose effect curve appeared to be U-shaped (with a small linear component) Non-cancer effects of exposure to A-bomb radiation deaths in 1950-62 are shown separately from later deaths . With this arrangement of the data (shown graphically in figs 2 and 3) it was possible to recognise differences between earlier and later deaths which find their strongest expression in the group that includes tuberculosis and other infection deaths. For this group, one of the two curves produced by plotting ratios of observed to expected deaths is deeply indented (1950-62 deaths) and the other is suggestive of a threshold dose effect 
Method
Provided that a variable has several levels (n) indexed by i we may define a generalised Spearman's rank correlation coefficient (r) by the formula: Under these conditions the variance of r is 1 V and the variance of S is Also the normal n-1 n-1. approximation to the distribution of S is improved if several such values are summated together with their variances.9 Therefore, we could make good use of the fact that for each cause of death listed in the RERF report there was a full complement of data for seven consecutive periods.
All that was necessary was to give the ratios in Non-cancer effects of exposure to A-bomb radiation There are obvious reasons why we cannot be certain that this is what actually happened. Nevertheless, we now know enough to be reasonably certain that all RERF risk estimates for cancer effects of radiation are based on false assumptions concerning some of the non-cancer deaths, and that rectification of these mistakes will necessarily affect their estimates of cancer effects and might bring them into line with estimates based on radiation workers.5 There is clearly a need for more certainty on these matters and, in our opinion, this could be achieved by epidemiologists with access to RERF data (1) obtaining separate identification of all infection deaths; (2) linking all deaths after 1950 with medical records for earlier years; and (3) applying to the full complement of data statistical methods which are suitable for solving the following problems: different reactions of high and low dose survivors to the basic causes of infection deaths; threshold dose effects of the radiation; and possible conflict between nonthreshold dose effects of radiation (such as mutations) and exclusively high dose effects (such as tissue damage).
